Equities

Medirom Healthcare Technologies Inc

MRM:NAQ

Medirom Healthcare Technologies Inc

Actions
Consumer DiscretionaryConsumer Discretionary
  • Price (USD)3.90
  • Today's Change-0.08 / -2.01%
  • Shares traded4.30k
  • 1 Year change-27.51%
  • Beta0.0369
Data delayed at least 15 minutes, as of Sep 20 2024 17:50 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments106605371
Total Receivables, Net1,2281,325855
Total Inventory14011419
Prepaid expenses258293111
Other current assets, total272727
Total current assets1,7592,3631,382
Property, plant & equipment, net2,5412,3802,249
Goodwill, net485539600
Intangibles, net921404391
Long term investments825353
Note receivable - long term9699102
Other long term assets865909975
Total assets6,8496,7475,753
LIABILITIES
Accounts payable138208231
Accrued expenses2,0252,1531,621
Notes payable/short-term debt40000
Current portion long-term debt/capital leases10099162
Other current liabilities, total8971,1821,182
Total current liabilities3,5613,6423,196
Total long term debt1,0511,150747
Total debt1,5511,249909
Deferred income tax------
Minority interest5.08----
Other liabilities, total2,0222,0152,018
Total liabilities6,6386,8075,961
SHAREHOLDERS EQUITY
Common stock201,2231,223
Additional paid-in capital1141,2651,265
Retained earnings (accumulated deficit)80(2545)(2694)
Treasury stock - common(3)(3)(3)
Unrealized gain (loss)------
Other equity, total------
Total equity211(59)(208)
Total liabilities & shareholders' equity6,8496,7475,753
Total common shares outstanding4.884.884.88
Treasury shares - common primary issue------
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.